Toggle navigation
Home
Search
Services
Blog
Contact
About
Broad Spectrum RNAi Antiviral against Hemorrhagic Fever Virus
Alnylam Pharmaceuticals, Cambridge, MA, United States
Search grants from Alnylam Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Transcriptional Mechanisms of Addiction-Related Neural Plasticity
PACAP and the response to stressors, neural mechanisms
Inference and Testing of Quantitative Models of Genetic Interaction
Crc/Pe for the Study of Psychopathology for the Elderly
Micropuncture Study of Kidney Function
Recently added grants:
A Gender Transformative Implementation Strategy with Providers to Improve HIV Outcomes in Uganda
Cellular and molecular mechanisms disrupted in 22q13 deletion syndrome and autism
Antipsychotics and the Risk of Unexpected Death in Children and Youth
Mechanisms of autophagic dysfunction in progranulin-related neurodegeneration
ACL-LIFE Life History Interview and Validation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI60012-2-0-1
Application #
7699990
Study Section
Project Start
2006-09-29
Project End
2010-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$7,547,998
Indirect Cost
Institution
Name
Alnylam Pharmaceuticals
Department
Type
DUNS #
115524410
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Comments
Be the first to comment on this grant